|
TC2N expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
6.074600E-01 |
| Stage1-vs-Stage3 |
7.636200E-01 |
| Stage1-vs-Stage4 |
4.917600E-03 |
| Stage2-vs-Stage3 |
5.382800E-01 |
| Stage2-vs-Stage4 |
1.408340E-02 |
| Stage3-vs-Stage4 |
3.010100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.64280034020692E-10 |
| Normal-vs-Asian |
1.62458935193399E-12 |
| Caucasian-vs-AfricanAmerican |
4.688800E-01 |
| Caucasian-vs-Asian |
2.155000E-01 |
| AfricanAmerican-vs-Asian |
1.980810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.567400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.32099999999402E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.876200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.055960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.557200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.335000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.858190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.135000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.963600E-01 |
| Classical-VS-Follicular |
8.019800E-01 |
| Classical-VS-Other |
7.303400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
8.804800E-01 |
| Tall-VS-Other |
7.089600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.943400E-01 |
| Follicular-VS-Normal |
1.62447832963153E-12 |
| Other-VS-Normal |
1.64778999999227E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.849600E-01 |
|
|
